Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 6;3(3):383–394. doi: 10.1158/2767-9764.CRC-22-0422

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 The Authors; Published by the American Association for Cancer Research

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

PMC Copyright notice

Fucosylated N-glycans are significantly altered in iCCA serum. (A) Serum N-glycan imaging workflow. Relative intensity quantification of bisected double fucosylated N-glycan (2158.791 m/z); (B) triantennary fucosylated N-glycan (2174.779 m/z); (C) triantennary double fucosylated N-glycan (2320.808 m/z); (D) and tetraantennary double fucosylated N-glycan (2361.849 m/z); (E) biantennary N-glycan (1339.463 m/z); (F) Each point in box plots represents a patient. The asterisk indicates statistical difference (Mann–Whitney, P < 0.001) and error bars represent the SD. Non iCCA n = 62 and iCCA n = 30. The mass defect used for each m/z value is based on TMA 1 run. For N-glycans, red triangle, fucose; blue square, N-acetylglucosamine; green circles, mannose; yellow circles, galactose.